Stay updated on Comparing Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Comparing Uproleselan in AML Clinical Trial page.

Latest updates to the Comparing Uproleselan in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry (v3.4.2) was added to the study record history. The outdated government-funding notice and the previous revision entry (v3.4.1) were removed.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding status and updated the revision tag to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check28 days agoChange DetectedAdded a glossary toggle and color-coded change highlights in the history view. Updated the revision to v3.4.0 and removed the No FEAR Act data label.SummaryDifference0.9%

- Check42 days agoChange DetectedThe Record History now includes a new entry Revision v3.3.4, and the previous entry Revision v3.3.3 is removed from the history list.SummaryDifference0.1%

- Check63 days agoChange DetectedAn entry 'Revision: v3.3.3' was added to the page's history, and the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page, reflecting a minor backend update with no changes to study data or navigation — to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Comparing Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Uproleselan in AML Clinical Trial page.